28 sep
|
HOSPITAL DEL MAR RESEARCH INSTITUTE
|
España
28 sep
HOSPITAL DEL MAR RESEARCH INSTITUTE
España
We are seeking a highly motivated Postdoctoral Researcher to join the NK cell immunotherapy team led by Dr. Aura Muntasell at the Hospital del Mar Research Institute.
Position Description
We offer a one-year contract, extendable to two years, to contribute to the development of an off-the-shelf, allogeneic TAR-NK cell product for cancer immunotherapy.
The researcher will participate in the development and standardization of the manufacturing process for SMAD4-edited human NK cells, including NK-cell expansion, CRISPR/Cas9-mediated genetic modification and cryopreservation, as well as the transfer and manufacturing of the clinical product in collaboration with the Banc de Sang i Teixits de Catalunya.
The position will also involve developing preclinical studies supporting IMPD submission, including pharmacokinetic/pharmacodynamic, biodistribution and efficacy studies in colorectal cancer models. Additional responsibilities include developing and optimizing assays for assessing the identity, purity, safety and potency of the final NK-cell product.
This is an excellent opportunity to work in a highly collaborative and multidisciplinary environment at the interface of NK-cell biology, cell therapy manufacturing and clinical translation.
Requirements
- Ph.D. in Immunology, Cell Biology, Biotechnology,
Biomedical Sciences or a related field.
- Experience with primary human NK cells isolation and culture.
- Experience with multiparametric flow cytometry and immunological assays.
- Knowledge of NK-cell biology, expansion and functional assays.
- Ability to independently design experiments, analyze data and troubleshoot protocols.
- Proficiency in English and ability to work effectively in a multidisciplinary team.
Additional Desirable Qualifications
Experience in one or more of the following will be considered an advantage:
- GMP-compliant cell therapy manufacturing and process development.
- Genetic modification of primary cells, particularly electroporation or CRISPR/Cas9.
- Xenograft, PDX or humanized mouse models, particularly colorectal cancer models.
- Development of cell-product identity, purity and potency assays.
- Familiarity with CMC development or IMPD preparation.
- Scientific reporting and/or project coordination.
Previous GMP or clinical cell therapy experience is not essential; a strong experimental background and willingness to work in a translational environment are highly valued.
Interested candidates should send an updated CV and optional references to
[email protected] by the end of October 2026.
📌 Postdoctoral Position in NK cell Immunotherapy for Cancer (España)
🏢 HOSPITAL DEL MAR RESEARCH INSTITUTE
📍 España